Genmab A/S Statistics
NASDAQ: GMABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
50.60-0.75 (-1.46%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Genmab A/S by the numbers
Genmab A/S has a market capitalization of $31.20 billion based on 616.59M shares outstanding. Its trailing P/E ratio is 43.2, above the 5-company peer median of 20.9, and its forward P/E is 32.0. The stock trades 17.7% above its 50-day average and 58.1% above its 200-day average.
Average daily trading volume is 4.18M shares, or about $211.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GMAB valuation vs. peer median
| Metric | GMAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $31.20B | $29.51B | +6% |
| P/E (TTM) | 43.2 | 20.9 | +107% |
| Forward P/E | 32.0 | 14.5 | +121% |
| Avg. volume | 4.18M | 3.15M | +33% |
Peer median across 8 companies: INSM, ZTS, ROIV, UTHR, RPRX, VTRS, ALNY, ONC.
Valuation
- Market cap
- $31.20B
- P/E (TTM)
- 43.25
- Forward P/E
- 32.03
- Price / sales (latest FY)
- 8.39
- EPS (TTM)
- $1.17
- Shares outstanding
- 616.59M
Price and trading
- Previous close
- 51.35
- Open
- 51.61
- Day range
- 50.24 – 51.72
- 52-week range
- 23.62 – 59.97
- 52-week change
- +66.17%
- Beta
- —
- Volume
- 2.90M
- Average volume
- 4.18M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 31.20B
- Pe
- 43.25
- Forward Pe
- 32.03
- Eps
- 1.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.97
- Week52 Low
- 23.62
- Avg Volume
- 4.18M
- Shares Outstanding
- 616.59M
- Ma50
- 42.98
- Ma200
- 32.01
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -15.62%
- Pct From52w Low
- 114.23%